CAS 2420564-02-7

Tixagevimab

CAS : 2420564-02-7

Tixagevimab (AZD8895) is a humanized antibody targeting the spike protein of SARS-CoV-2, with antiviral activity.

Degré de pureté : 95%

Couleur et forme : Liquid

Masse moléculaire : 146.48 kDa

Ref: TM-T76976

Tixagevimab

CAS : 2420564-02-7

Monoclonal antibody targeting the surface spike protein of SARS-CoV-2

Ref: 3D-CLA1638